Patent Grant
7709648
The present invention concerns processes for preparation of 2-substituted-5-(1-alkylthio)alkylpyridines.
The 2-substituted-5-(1-alkylthio)alkylpyridines are useful intermediates for the preparation of certain new insecticides; see, for example, U.S. Patent Publication 2005/0228027. It would be advantageous to produce 2-substituted-5-(1-alkylthio)alkylpyridines efficiently and in high yield.
One aspect of the present invention concerns a process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridine (I),
wherein
R1 and R2 independently represent H, C1-C4 alkyl, or either of R1 or R2 taken together with R3 represent a 4- to 6-membered saturated ring, or R1 taken together with R2 represent a 3- to 6-membered saturated ring optionally substituted with an O or a N atom;
R3 represents C1-C4 alkyl or R3 taken together with either of R1 or R2 represent a 4- to 6-membered saturated ring; and
R4 represents C1-C4 alkyl or C1-C4 haloalkyl;
which comprises:
a) condensing a substituted enone (II),
wherein
R4 is as previously defined; and
R5 and R6 independently represent C1-C4 alkyl;
with an enamine (III),
wherein
R1, R2 and R3 are as previously defined; and
R7 and R8 independently represent C1-C4 alkyl or R7 and R8 taken together with N represent a 5-membered saturated or unsaturated ring;
b) cyclizing the reaction mixture from step a) in the presence of ammonia or a reagent capable of generating ammonia to produce a 2,3,5-substituted pyridine (IV),
wherein
R1, R2, R3, R4 and R6 are as previously defined; and
c) saponifying and decarboxylating the 2,3,5-substituted pyridine (IV) to give 2-substituted-5-(1-alkylthio)alkylpyridine (I). This method is particularly well suited to prepare compounds in which R4 represents CF3.
Another aspect of the invention concerns the intermediate nicotinic acid derivatives of the Formula (IV)
wherein
R1 and R2 independently represent H, C1-C4 alkyl, or either of R1 or R2 taken together with R3 represent a 4- to 6-membered saturated ring, or R1 taken together with R2 represent a 3- to 6-membered saturated ring optionally substituted with an O or a N atom;
R3 represents C1-C4 alkyl or R3 taken together with either of R1 or R2 represent a 4- to 6-membered saturated ring;
R4 represents C1-C4 alkyl or C1-C4 haloalkyl; and
R6 represents H or C1-C4 alkyl.
Unless specifically limited otherwise, the term “alkyl” (including derivative terms such as “haloalkyl”), as used herein, include straight chain, branched chain, and cyclic groups. Thus, typical alkyl groups are methyl, ethyl, 1-methylethyl, propyl, 1,1-dimethylethyl, and cyclopropyl. The term “halogen” includes fluorine, chlorine, bromine and iodine. The term “haloalkyl” includes alkyl groups substituted with any number from one to the maximum possible number of halogen atoms.
One aspect of the present invention concerns a process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridine (I),
wherein
R1 and R2 independently represent H, C1-C4 alkyl, or either of R1 or R2 taken together with R3 represent a 4- to 6-membered saturated ring, or R1 taken together with R2 represent a 3- to 6-membered saturated ring optionally substituted with an O or a N atom;
R3 represents C1-C4 alkyl or R3 taken together with either of R1 or R2 represent a 4- to 6-membered saturated ring; and
R4 represents C1-C4 alkyl or C1-C4 haloalkyl;
which comprises:
a) condensing a substituted enone (II),
wherein
R4 is as previously defined; and
R5 and R6 independently represent C1-C4 alkyl;
with an enamine (III),
wherein
R1, R2 and R3 are as previously defined; and
R7 and R8 independently represent C1-C4 alkyl or R7 and R8 taken together with N represent a 5-membered saturated or unsaturated ring;
b) cyclizing the reaction mixture from step a) in the presence of ammonia or a reagent capable of generating ammonia to produce a 2,3,5-substituted pyridine (IV),
wherein
R1, R2, R3, R4 and R6 are as previously defined; and
c) saponifying and decarboxylating the 2,3,5-substituted pyridine (IV) to give 2-substituted-5-(1-alkylthio)alkylpyridine (I).
The substituted enone (II) starting materials are commercially available or can be prepared from the corresponding keto ester substrates and alkylorthoformates. Typically, acetoacetates are condensed with trialkylorthoformates to yield compounds of type (II). Enamines (III) starting materials can be conveniently prepared from the addition of a suitably substituted amine to an appropriately substituted aldehyde in the presence of a water adsorbing material, with or without a suitable solvent. Typically, the appropriate substituted propionaldehyde is reacted with an anhydrous disubstituted amine at about −20° C. to about 20° C. in the presence of a desiccant such as anhydrous potassium carbonate, and the product is isolated by distillation.
In steps a) and b), approximately equimolar quantities of the substituted enone (II) and the enamine (III) and ammonia are required in the process, although 2-4 fold excesses of the ammonia or the ammonia precursor are often preferred.
Typical reagents capable of generating ammonia include, for example, 1) an ammonium salt of an acid, preferably an organic acid, 2) formamide, or 3) formamide with an acid or acid salt. The ammonium salt of any aliphatic or aromatic organic acid can be used, but for convenience of processing, the ammonium salts of C1-C4 alkanoic acids are preferred. Ammonium formate and ammonium acetate are preferred.
Step a) is illustratively conducted in a polar high-boiling solvent that is miscible with water. Preferred solvents include: amides such as formamide, dimethyl formamide, dimethyl acetamide; alcohols such as methanol, ethanol, isopropanol, (2-methoxy)ethanol; and alkylnitriles including acetonitrile.
The reaction is conducted at a temperature from about −20° C. to about 150° C. Temperatures from about 0° C. to about 80° C. are preferred.
The product is isolated by conventional techniques such as silica gel chromatography or fractional distillation.
In a typical reaction, the substituted enone (II) and enamine (III) are dissolved in the polar solvent at about −5° C. to about 20° C. and agitated until the substituted enone (II) and enamine (III) are consumed. In step b), the ammonium salt of the organic acid is then added, and the mixture is heated at about 50° C. to about 150° C. until the reaction is complete. After dissolving in a non-water miscible solvent and washing with water and, optionally, brine, the 2,3,5-substituted pyridine (IV) is isolated by silica gel column chromatography or by vacuum distillation.
In step c), 2,3,5-substituted pyridine (TV) is saponified by well-known procedures with base, preferably an alkali metal hydroxide such as lithium hydroxide, at about 0° C. to about 50° C. in a polar solvent that is miscible with water, such as tetrahydrofuran. The resulting pyridine carboxylate salt is neutralized and is then decarboxylated by well-known procedures such as, for example, by heating in a high boiling solvent such as DowTherm A (available by The Dow Chemical Company), optionally with copper powder, at temperatures between about 150° C. and about 250° C. to obtain 2-substituted-5-(1-alkylthio)alkylpyridine (I), which can be isolated by conventional methods such as silica gel chromatography or vacuum distillation.
The following examples are presented to illustrate the invention.
To a dry 5000 milliliter (mL) round bottom flask equipped with mechanical stirrer, nitrogen inlet, addition funnel, and thermometer, was charged 591 g (4.27 moles) of dry granular potassium carbonate and 1428 ml (17.1 moles) of anhydrous pyrrolidine. The mixture was stirred under a atmosphere of nitrogen, and cooled to 4° C. with an ice bath, after which 1050 ml (8.9 moles) of 3-methyl-thiobutyraldehyde was added at a rate that maintains the temperature below 10° C. Upon the completion of the addition, the cooling bath was removed and the reaction was allowed to reach room temperature. The reaction contents were then filtered through a sintered glass filter funnel to remove the solids and the solids were washed with 200 ml of anhydrous ethyl ether. The filtrate was concentrated under vacuum on a rotary evaporator until all of the pyrrolidine was removed to afford 1,519 g of 1-(3-methylthiobut-1-enyl)pyrrolidine as a red liquid. 1H NMR CDCl3 δ 1.36 (d, 3H), 1.85 (m, 4H), 2.02 (s, 3H), 3.02 (m, 4H), 3.26 (q, 1H), 3.98 (dd, 1H), 6.25 (d, 1H).
To a dry 50 mL round bottom flask equipped with magnetic stirrer, nitrogen inlet, addition funnel, and thermometer, was charged the 1-(3-methyl-thiobut-1-enyl)pyrrolidine (5.0 g, 0.0291 mol) and 100 mL of dry acetonitrile. The 2-[1-ethoxymethylidene]-4,4,4-trifluoro-3-oxo-butyric acid ethyl ester (7.0 g, 0.0291 mol) was added dropwise, and the reaction was stirred at room temperature for 1 hour. An aliquot was analyzed by gas chromatography (GC) which indicated that no starting material remained. Ammonium acetate (5.0 g, 0.058 mol) was added to the dark red solution and the reaction was heated at reflux for 30 minutes. Cooled and concentrated under vacuum on a rotary evaporator, the crude product was purified by silica gel column chromatography with a gradient of 5% ethyl acetate, 95% hexane to 50% ethyl acetate 50% hexane over 20 minutes to afford 2.5 g of the title compound as a pale yellow oil. 1H NMR (CDCl3): δ 1.42 (t, 3H), 1.62 (d, 3H), 1.96 (s, 3H), 3.94 (q, 1H), 4.43 (q, 2H), 8.08 (s, 1H), and 8.71 (s, 1H).
To a dry 50 mL glass vial equipped with magnetic stirrer, and nitrogen inlet, was charged 0.5 g (0.00170 moles) of 5-(1-methylthioethyl)-2-trifluoromethylnicotinic acid ethyl ester, and 10 mL of tetrahydrofuran (THF). The solution was cooled to about 0° C. and 5.1 mL of 1N aqueous lithium hydroxide solution (0.00511 moles) was added slowly via syringe. The reaction was stirred at 0° C. for 1 hour, then overnight at ambient temperature. An aliquot was analyzed by thin layer chromatography (TLC) and high performance liquid chromatography (HPLC), which indicated that the reaction was essentially complete. The mixture was acidified to pH=2 with 1M aqueous hydrochloric acid, and extracted with 3 aliquots of 50 mL of ethyl acetate. The extract was dried over anhydrous magnesium sulfate (MgSO4), filtered, and concentrated under vacuum on a rotary evaporator to afford 0.410 g of the title compound as a tan solid. 1H NMR (CDCl3): δ 1.66 (d, 3H), 1.96 (s, 3H), 3.98 (q, 1H), 8.01 (bs, 1H), 8.30 (s, 1H), and 8.80 (s, 1H).
To a dry 50 mL round bottom flask equipped with magnetic stirrer, nitrogen inlet, thermometer, and reflux condenser was charged 0.35 g (0.00132 moles) of 5-(1-methylthioethyl)-2-trifluoromethylnicotinic acid, 0.17 g (0.00264 moles) of copper powder and 10 mL of DowTherm A. The reaction was heated at 240° C. for 1 hour, then cooled to room temperature. The reaction mixture was extracted with 3 aliquots of 50 mL of ethyl acetate, and washed with 50 mL of water and 50 mL of saturated aqueous sodium chloride solution. The organic extract was dried over anhydrous magnesium sulfate, filtered, and concentrated under vacuum on a rotary evaporator. The crude product thus obtained was chromatographed on silica gel with a gradient of 100% hexane to 50% ethyl acetate, 50% hexane. The pure fractions were combined, and concentrated under vacuum on a rotary evaporator to afford 0.13 g of the title compound as a pale yellow oil. 1H NMR (CDCl3): δ 1.62 (d, 3H), 1.94 (s, 3H), 3.93 (q, 1H), 7.68 (d, 1H), 7.90 (d, 1H), and 8.66 (s, 1H).
| Number | Name | Date | Kind |
|---|---|---|---|
| 3711486 | Torba et al. | Jan 1973 | A |
| 3787420 | Torba et al. | Jan 1974 | A |
| 3852279 | Krapcho et al. | Dec 1974 | A |
| 4692184 | Lee | Sep 1987 | A |
| 4747871 | Ruminski et al. | May 1988 | A |
| 4948896 | Nagao | Aug 1990 | A |
| 4973695 | Yamashita et al. | Nov 1990 | A |
| 5053516 | Hartmann et al. | Oct 1991 | A |
| 5099023 | Miller et al. | Mar 1992 | A |
| 5099024 | Pulwer et al. | Mar 1992 | A |
| 5118809 | Cevasco et al. | Jun 1992 | A |
| 5124458 | Cevasco et al. | Jun 1992 | A |
| 5169432 | Auinbauh et al. | Dec 1992 | A |
| 5225560 | Cevasco et al. | Jul 1993 | A |
| 5227491 | Doehner, Jr. | Jul 1993 | A |
| 5229519 | Zhang et al. | Jul 1993 | A |
| 20030078430 | Satake et al. | Apr 2003 | A1 |
| 20040158067 | Hutchison et al. | Aug 2004 | A1 |
| 20050228027 | Zhu et al. | Oct 2005 | A1 |
| 20060199964 | Jackson et al. | Sep 2006 | A1 |
| 20070249837 | Gebhardt et al. | Oct 2007 | A1 |
| Number | Date | Country |
|---|---|---|
| WO 2007095229 | Aug 2007 | WO |
| PCTUS2007003779 | Jan 2009 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20080194830 A1 | Aug 2008 | US |
